NEW YORK (GenomeWeb News) — Bruker Daltonics said today that Leiden University Medical Center in the Netherlands has installed two of the company's FTMS systems for use in its proteomics research.
Leiden's researchers will use the company's 12 Tesla and 15 Tesla FTMS systems in protein characterization and analysis studies, Bruker said.
"In the last few years, the LUMC has invested significantly in creating a state-of-the-art proteomics infrastructure," and the new Bruker systems will enable more "in-depth characterization and quantitative analysis of the large number of sample generally encountered in clinical studies," Leiden researcher Andre Deelder said in a statement.
LUMC is conducting studies of proteomes and metabolomes of different body fluids from various patient cohorts in "bottom-up proteomics" studies.